×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Event Driven Monitor – October 6, 2023

  • October 6, 2023
Subscribe to receive our Event Driven Monitor by email every morning before the market opens. Merger Arbitrage ORTX: Orchard Therapeutics to be acquired by Kyowa Kirin Co., Ltd. for $387.4 million. Upon completion of the merger, shareholders of Orchard Therapeutics will receive $16.00 per ADS in cash. Orchard shareholders will also hold an additional contingent value right (CVR) of $1.00 per ADS. SP: SP Plus Corporation to be acquired by Metropolis Technologies for $1.9 billion or $54 per share in cash. ATVI: Seeking Alpha summarized a CTFN report that the UK may make a decision on its review of the Microsoft (MSFT) deal as soon as next week. According to the report, the UK CMA is on target to deliver its decision on the acquisition of Activision (ATVI) before the October 18 deadline. HZNP: Amgen (AMGN) won approval from the High Court of Ireland for its planned $28 billion purchase of Horizon Therapeutics (HZNP). Horizon stock is scheduled to be halted in the after-hours session on Thursday if the Irish High Court sanctions the scheme of arrangement at the court hearing. SCU: Sculptor Capital Management and Rithm Capital (RITM) received written confirmation of the Hong Kong Securities and Futures Commission (SFC) approval. SCU: According to...

Only plus or premium subscribers can access this post. Subscribe today.